Nitazoxanide: a review of its use in the treatment of gastrointestinal infections (Q28242385)

Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses

Europe PubMed Central

title

Nitazoxanide: a review of its use in the treatment of gastrointestinal infections (English)

0 references

2

Monique P Curran

0 references

author name string

Vanessa R Anderson

series ordinal

1

0 references

language of work or name

English

0 references

publication date

2007

0 references

published in

Drugs

0 references

volume

67

0 references

issue

13

0 references

page(s)

1947-67

0 references

cites work

2 references

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767130-00015

21 January 2018

12 December 2020

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767130-00015

Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells

21 January 2018

1 reference

12 December 2020

Parasitic infections of the intestine

1 reference

12 December 2020

Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole.

1 reference

12 December 2020

Giardia lamblia carriage in Israeli Bedouin infants: risk factors and consequences

1 reference

12 December 2020

Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide

1 reference

12 December 2020

Nitazoxanide treatment for giardiasis and cryptosporidiosis in children

1 reference

12 December 2020

Nitazoxanide: an important advance in anti-parasitic therapy

1 reference

12 December 2020

Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model

1 reference

12 December 2020

In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms

1 reference

12 December 2020

Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species

1 reference

12 December 2020

Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole.

1 reference

12 December 2020

Transient neonatal Cryptosporidium parvum infection triggers long-term jejunal hypersensitivity to distension in immunocompetent rats

1 reference

12 December 2020

A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico

1 reference

12 December 2020

Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru

1 reference

12 December 2020

Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections

1 reference

12 December 2020

Nitazoxanide pharmacokinetics and tolerability in man during 7 days dosing with 0.5 g and 1 g b.i.d

1 reference

12 December 2020

Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide

1 reference

12 December 2020

In vitro efficacies of nitazoxanide and other thiazolides against Neospora caninum tachyzoites reveal antiparasitic activity independent of the nitro group

1 reference

12 December 2020

Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide

1 reference

12 December 2020

Consensus Statement of IAP National Task Force: status report on management of acute diarrhea.

1 reference

12 December 2020

In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells

1 reference

12 December 2020

Blastocystis hominis: neutral red supravital staining and its application to in vitro drug sensitivity testing

1 reference

12 December 2020

Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico

1 reference

12 December 2020

In vitro and in vivo activities of nitazoxanide against Clostridium difficile

1 reference

12 December 2020

In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes

1 reference

12 December 2020

The disappearing arsenal of antiparasitic drugs

1 reference

12 December 2020

Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models

1 reference

12 December 2020

In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis

1 reference

12 December 2020

Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species

1 reference

12 December 2020

Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial

1 reference

12 December 2020

Nitazoxanide for the treatment of Clostridium difficile colitis

1 reference

12 December 2020

Rotavirus vaccine (RotaTeq).

1 reference

12 December 2020

Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model

1 reference

12 December 2020

Prevention and treatment of cryptosporidiosis in immunocompromised patients

1 reference

12 December 2020

In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites

1 reference

12 December 2020

Nitazoxanide vs albendazole against intestinal parasites in a single dose and for three days

1 reference

12 December 2020

Evaluation of the in vitro effect of albendazole, metronidazole and nitazoxanide on viability and structure of Giardia lamblia cysts.

1 reference

12 December 2020

Antiparasitic therapy in children

1 reference

12 December 2020

A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides

1 reference

12 December 2020

Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers

1 reference

12 December 2020

Efficacy of nitazoxanide, tizoxanide and tizoxanide/albendazole sulphoxide combination against Taenia crassiceps cysts

1 reference

12 December 2020

Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru

1 reference

12 December 2020

Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm

1 reference

12 December 2020

Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients

1 reference

12 December 2020

Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial

1 reference

12 December 2020

Nitazoxanide for persistent diarrhoea in Zambian acquired immune deficiency syndrome patients: a randomized-controlled trial

1 reference

12 December 2020

Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity.

1 reference

12 December 2020

Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children.

1 reference

12 December 2020

Treatment options for the eradication of intestinal protozoa

1 reference

12 December 2020

Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori

1 reference

12 December 2020

Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model.

1 reference

12 December 2020

Gastrointestinal infections in immunocompromised hosts

1 reference

12 December 2020

Cryptosporidiosis in children.

1 reference

12 December 2020

Treatment of infectious diarrhea in children

1 reference

12 December 2020

Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru

1 reference

12 December 2020

Successful treatment of human fascioliasis with nitazoxanide

1 reference

12 December 2020

Nitroheterocyclic drugs with broad spectrum activity

1 reference

12 December 2020

Nematocidal activity of nitazoxanide in laboratory models

1 reference

12 December 2020

Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni

1 reference

12 December 2020

American Gastroenterological Association medical position statement: guidelines for the evaluation and management of chronic diarrhea

1 reference

12 December 2020

Practice guidelines for the management of infectious diarrhea

1 reference

12 December 2020

Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial

1 reference

12 December 2020

Nitazoxanide: pharmacokinetics and metabolism in man

1 reference

12 December 2020

Nitazoxanide in treatment of Helicobacter pylori: a clinical and in vitro study

1 reference

12 December 2020

Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis

1 reference

12 December 2020

Structure-activity relationships from in vitro efficacies of the thiazolide series against the intracellular apicomplexan protozoan Neospora caninum

1 reference

12 December 2020

Epidemiology and management of infectious diseases in international adoptees

1 reference

12 December 2020

Nitazoxanide: a new thiazolide antiparasitic agent

1 reference

12 December 2020

In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae

1 reference

12 December 2020

Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture

1 reference

12 December 2020